Metabolomics in the Diagnosis and Treatment of Asthma in Children
Recruiting now
Conditions studied: Asthma
In brief
The goal of this observational study is to learn about the metabolomic profile of blood and urine in children 12-17 years with asthma. The main question it aims to answer is: • Are there metabolites in the blood and urine that are specific for asthma exacerbation? Participants already receive standard therapy as part of their regular medical care for asthma.
Key facts
- Study ID
- NCT07280364
- Run by
- I.M. Sechenov First Moscow State Medical University
- People needed
- 100
- Starts
- 2024-03-13
- Expected to finish
- 2026-08-01
- Last updated by the study team
- 2026-01-28
Who can join
Age: 12 and older, up to 17. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Age from 12 to 17 years old
- Confirmed diagnosis of asthma
- Informed voluntary consent to participate in the study
You may not qualify if…
- age under 12 years
- no established diagnosis of asthma
- concomitant severe somatic, metabolic, and endocrine diseases
- patient's withdrawal of informed consent
Where it is running
- I.M. Sechenov First Moscow State Medical University (Sechenov University) — Moscow, Russia (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.